Early data analysis suggests that the COVID-19 vaccine made in China is 86% effective in preventing infection.
The· vaccineDeveloped by the state-owned company Sinopharm, it was already granted an “emergency permit” by the United Arab Emirates in September, allowing front-line healthcare professionals to receive shots. statement From the government. Currently, after reviewing data from late-stage clinical trials, the UAE has approved widespread use of the vaccine.
“The EUA vaccination program has effectively protected front-line workers in the UAE,” a government statement said. Official approval of the vaccine “guides a way to comprehensively protect the population and open the economy responsibly.”
Relation: 20 of the worst fads and pandemics ever
A statement from the United Arab Emirates states that the government has reviewed the “interim analysis” conducted by Shinofarm, but does not specify whether it has also conducted its own review of raw data. The New York Times reported.. Preliminary analysis suggests that the vaccine is 86% effective, but this number can change once data from all ongoing trials are finalized. According to The Times, Shinofarm is currently conducting clinical trials in 10 countries.
Sinopharm’s analysis also shows that the vaccine does not raise serious safety concerns and that 99% of people receiving injections neutralize. antibodyLatch to Virus According to the statement, it blocks the infection of cells.Neutralizing antibody does not appear Warranty Humans are not infected with COVID-19 because antibodies need to be of a particular quality, number and type for maximum protection. This may help explain why the vaccine appears to be 86% effective instead of 99%.
Nevertheless, analysis shows that the vaccine protects 100% of moderate to severe cases of COVID-19, but this number may change as more study data become available.
Live Science previously reported that the Sinopharm vaccine contains an inactivated form of SARS-CoV-2, the virus that causes COVID-19. Once inactivated or “killed,” the virus can no longer cause illness, but instead trains the immune system to fight pathogens.
It is unclear when and when the United Arab Emirates will launch a national vaccination program with the Synofarm vaccine, but Morocco has announced plans to use the vaccine in its own program, Associated Press. Reported. The country wants to vaccinate 80% of its population with both the Sinofarm vaccine and the vaccine developed by the University of Oxford and AstraZeneca.
Originally published in Live Science.
The COVID-19 vaccine made in China is 86% effective, and the initial data is
Source link The COVID-19 vaccine made in China is 86% effective, and the initial data is